Fingolimod Hydrochloride
Showing 1 - 25 of 1,879
Chemo-Induced Peripheral Neuropathy, Numbness, Pain Trial in Rochester, Columbus (Fingolimod, Fingolimod Hydrochloride,
Active, not recruiting
- Chemotherapy-Induced Peripheral Neuropathy
- +3 more
- Fingolimod
- +2 more
-
Rochester, Minnesota
- +1 more
Jan 17, 2023
Stroke, Inflammation Trial in Hangzhou (Fingolimod)
Withdrawn
- Stroke
- Inflammation
-
Hangzhou, Zhejiang, ChinaThe second affiliated hospital of Zhejiang University
Jul 15, 2021
Pharmacogenetics of Liver Toxicity in Multiple Sclerosis Treated
Recruiting
- Multiple Sclerosis
- Genetic polymorphism
- Measurement of fingolimod and fingolimod-phosphate concentrations
-
Caen, FranceCaen University Hospital
Aug 23, 2022
Stroke Inflammation Trial in Fuzhou (Fingolimod)
Recruiting
- Stroke Inflammation
-
Fuzhou, ChinaThe First Affiliated Hospital of Fujian Medical University
Apr 12, 2022
Interstitial Fibrosis, Kidney Transplant; Complications, Kidney Transplant Rejection Trial in Houston (Fingolimod, Placebo)
Enrolling by invitation
- Interstitial Fibrosis
- +6 more
- Fingolimod
- Placebo
-
Houston, TexasHouston Methodist Research Institute
Jan 23, 2023
Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Ocrelizumab Placebo, Fingolimod)
Recruiting
- Relapsing-Remitting Multiple Sclerosis
- Ocrelizumab
- +3 more
-
La Jolla, California
- +66 more
Jan 27, 2023
Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Fingolimod, Placebo capsule)
Recruiting
- Multiple Sclerosis
- Interferon beta-1a
- +3 more
-
Birmingham, Alabama
- +106 more
Jan 13, 2023
Diabetes, Type 2 Trial in Shenyang (Fingolimod, guideline-based treatment for DM)
Recruiting
- Diabetes Mellitus, Type 2
- Fingolimod
- guideline-based treatment for DM
-
Shenyang, ChinaDepartment of Neurology, General Hospital of Northern Theater Co
Mar 31, 2022
Relationship Between Oral DMT Burden and Adherence in MS
Enrolling by invitation
- Multiple Sclerosis
- Adherence, Medication
- Cladribine
- +5 more
-
Melbourne, Victoria, AustraliaMonash University
Aug 28, 2022
Relapsing Multiple Sclerosis (RMS) Trial in China (Fingolimod 0.5mg)
Recruiting
- Relapsing Multiple Sclerosis (RMS)
- Fingolimod 0.5mg
-
Beijing, Beijing, China
- +12 more
Feb 3, 2022
Bioequivalence, Safety Trial in Mount-Royal (Fingolimod 0.5 mg capsules- Test drug)
Completed
- Bioequivalence
- Safety
- Fingolimod 0.5 mg capsules- Test drug
-
Mount-Royal, Quebec, CanadaAlgorithme Pharma Inc.
Dec 6, 2021
Impact of Fingolimod Adherence on Outcomes
Completed
- Multiple Sclerosis
-
East Hanover, New JerseyNovartis Investigational Site
Dec 15, 2021
Intracerebral Hemorrhage, Cerebral Edema, Stroke Hemorrhagic Trial in Winston-Salem (Fingolimod 0.5 mg, Placebo, Standard of
Recruiting
- Intracerebral Hemorrhage
- +4 more
- Fingolimod 0.5 mg
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Nov 28, 2022
Czech Pharmaco-epidemiological Study on Disease Modifying Drugs
Completed
- Multiple Sclerosis
- interferons, glatiramer acetate, teriflunomide, dimethyl fumarate, alemtuzumab, cladribine, fingolimod, ponesimod, rituximab, ocrelizumab, ofatumumab, natalizumab
-
Prague, CzechiaIMPULS Endowment Fund
Mar 7, 2023
Stroke, Inflammation Trial in Hangzhou (Fingolimod, Placebo)
Unknown status
- Stroke
- Inflammation
- Fingolimod
- Placebo
-
Hangzhou, Zhejiang, ChinaThe second affiliated hospital of Zhejiang University
Jul 17, 2021
Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate
Recruiting
- Multiple Sclerosis
- Diroximel Fumarate
- +8 more
-
Eden Prairie, MinnesotaOptumInsight
Jan 9, 2023
Multiple Sclerosis Trial in Berlin, Potsdam (Verum arm receiving Gilenya®, Active Comparator receiving Extavia®)
Terminated
- Multiple Sclerosis
- Verum arm receiving Gilenya®
- Active Comparator receiving Extavia®
-
Berlin, Germany
- +1 more
Jul 28, 2021
Multiple Sclerosis Treated Fingolimod or Other Approved
Completed
- Multiple Sclerosis
- other disease-modifying therapy
- Fingolimod
-
Birmingham, Alabama
- +237 more
Dec 28, 2021
Relapsing Multiple Sclerosis Trial in United States (Fingolimod)
Completed
- Relapsing Multiple Sclerosis
-
Birmingham, Alabama
- +65 more
Oct 6, 2021